Keenova Therapeutics plc announced today that it will present a live treatment procedure with XIAFLEX® (collagenase clostridium histolyticum) for Dupuytren's contracture (DC) during the American ...
Analysis to Be Presented at the American Association for Hand Surgery Meeting DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a ...
Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or CCH) will be shared at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback